MKS Instruments, Inc. (NASDAQ:MKSI – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2025 EPS estimates for shares of MKS Instruments in a research report issued to clients and investors on Tuesday, January 21st. Cantor Fitzgerald analyst M. Prisco anticipates that the scientific and technical instruments company will post earnings of $8.00 per share for the year. The consensus estimate for MKS Instruments’ current full-year earnings is $6.34 per share.
Several other research firms have also commented on MKSI. Citigroup upgraded shares of MKS Instruments from a “neutral” rating to a “buy” rating and set a $130.00 price target for the company in a report on Monday, January 6th. The Goldman Sachs Group reduced their price objective on shares of MKS Instruments from $143.00 to $128.00 and set a “neutral” rating for the company in a research note on Friday, January 10th. Needham & Company LLC reiterated a “buy” rating and set a $156.00 price objective on shares of MKS Instruments in a research note on Wednesday, January 15th. Benchmark reiterated a “buy” rating and set a $142.00 price objective on shares of MKS Instruments in a research note on Monday, November 18th. Finally, JPMorgan Chase & Co. started coverage on shares of MKS Instruments in a research note on Friday, December 13th. They set an “overweight” rating and a $145.00 price objective for the company. Four research analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $141.75.
MKS Instruments Trading Up 0.4 %
NASDAQ:MKSI opened at $122.69 on Wednesday. MKS Instruments has a one year low of $97.54 and a one year high of $147.40. The company has a debt-to-equity ratio of 1.98, a quick ratio of 2.21 and a current ratio of 3.42. The firm has a market cap of $8.26 billion, a P/E ratio of 272.64, a P/E/G ratio of 0.60 and a beta of 1.66. The firm has a 50-day simple moving average of $111.44 and a 200-day simple moving average of $112.82.
MKS Instruments (NASDAQ:MKSI – Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The scientific and technical instruments company reported $1.72 EPS for the quarter, beating the consensus estimate of $1.45 by $0.27. MKS Instruments had a net margin of 0.90% and a return on equity of 15.79%. The business had revenue of $896.00 million during the quarter, compared to analyst estimates of $874.29 million. During the same quarter in the previous year, the business posted $1.46 EPS. The company’s quarterly revenue was down 3.9% compared to the same quarter last year.
Institutional Trading of MKS Instruments
Several hedge funds and other institutional investors have recently added to or reduced their stakes in MKSI. Massmutual Trust Co. FSB ADV grew its position in MKS Instruments by 196.9% during the third quarter. Massmutual Trust Co. FSB ADV now owns 288 shares of the scientific and technical instruments company’s stock valued at $31,000 after buying an additional 191 shares during the period. UMB Bank n.a. grew its position in shares of MKS Instruments by 53.7% in the third quarter. UMB Bank n.a. now owns 349 shares of the scientific and technical instruments company’s stock valued at $38,000 after purchasing an additional 122 shares during the period. Quarry LP acquired a new stake in shares of MKS Instruments in the second quarter valued at about $39,000. Versant Capital Management Inc grew its position in shares of MKS Instruments by 58.0% in the fourth quarter. Versant Capital Management Inc now owns 433 shares of the scientific and technical instruments company’s stock valued at $45,000 after purchasing an additional 159 shares during the period. Finally, Blue Trust Inc. grew its position in shares of MKS Instruments by 424.1% in the fourth quarter. Blue Trust Inc. now owns 414 shares of the scientific and technical instruments company’s stock valued at $45,000 after purchasing an additional 335 shares during the period. Institutional investors and hedge funds own 99.79% of the company’s stock.
Insider Activity
In other news, Director Jacqueline F. Moloney sold 300 shares of the company’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $114.80, for a total value of $34,440.00. Following the sale, the director now directly owns 9,983 shares of the company’s stock, valued at $1,146,048.40. This represents a 2.92 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Elizabeth Mora sold 275 shares of the firm’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $113.41, for a total transaction of $31,187.75. Following the sale, the director now owns 17,659 shares in the company, valued at approximately $2,002,707.19. This represents a 1.53 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.51% of the company’s stock.
MKS Instruments Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Monday, November 25th were issued a $0.22 dividend. This represents a $0.88 annualized dividend and a dividend yield of 0.72%. The ex-dividend date was Monday, November 25th. MKS Instruments’s dividend payout ratio (DPR) is currently 195.56%.
About MKS Instruments
MKS Instruments, Inc provides foundational technology solutions to semiconductor manufacturing, electronics and packaging, and specialty industrial applications in the United States, Germany, China, South Korea, and internationally. It operates through Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Material Solutions Division (MSD) segments.
See Also
- Five stocks we like better than MKS Instruments
- Stock Market Upgrades: What Are They?
- Oracle Announces Game-Changing News for the AI Industry
- 5 discounted opportunities for dividend growth investors
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Energy and Oil Stocks Explained
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for MKS Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments and related companies with MarketBeat.com's FREE daily email newsletter.